Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Peripheral Intervention Drug-Eluting Devices market report explains the definition, types, applications, major countries, and major players of the Peripheral Intervention Drug-Eluting Devices market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Medtronic plc
Biosensors International Group Ltd
Boston Scientific Corporation
B Braun Melsungen AG
Cardinal Health
Terumo Corporation
St Jude Medical Inc
CR Bard Inc
The Lubrizol Corporation
Abbott Laboratories
By Type:
Plain Old Balloon Angioplasty (POBA)
Percutaneous Transluminal Angioplasty (PTA)
By End-User:
Drug-Eluting Balloons
Drug-Eluting Stents
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Peripheral Intervention Drug-Eluting Devices Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Peripheral Intervention Drug-Eluting Devices Outlook to 2028- Original Forecasts
-
2.2 Peripheral Intervention Drug-Eluting Devices Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Peripheral Intervention Drug-Eluting Devices Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Peripheral Intervention Drug-Eluting Devices Market- Recent Developments
-
6.1 Peripheral Intervention Drug-Eluting Devices Market News and Developments
-
6.2 Peripheral Intervention Drug-Eluting Devices Market Deals Landscape
7 Peripheral Intervention Drug-Eluting Devices Raw Materials and Cost Structure Analysis
-
7.1 Peripheral Intervention Drug-Eluting Devices Key Raw Materials
-
7.2 Peripheral Intervention Drug-Eluting Devices Price Trend of Key Raw Materials
-
7.3 Peripheral Intervention Drug-Eluting Devices Key Suppliers of Raw Materials
-
7.4 Peripheral Intervention Drug-Eluting Devices Market Concentration Rate of Raw Materials
-
7.5 Peripheral Intervention Drug-Eluting Devices Cost Structure Analysis
-
7.5.1 Peripheral Intervention Drug-Eluting Devices Raw Materials Analysis
-
7.5.2 Peripheral Intervention Drug-Eluting Devices Labor Cost Analysis
-
7.5.3 Peripheral Intervention Drug-Eluting Devices Manufacturing Expenses Analysis
8 Global Peripheral Intervention Drug-Eluting Devices Import and Export Analysis (Top 10 Countries)
-
8.1 Global Peripheral Intervention Drug-Eluting Devices Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Peripheral Intervention Drug-Eluting Devices Export by Region (Top 10 Countries) (2017-2028)
9 Global Peripheral Intervention Drug-Eluting Devices Market Outlook by Types and Applications to 2022
-
9.1 Global Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Plain Old Balloon Angioplasty (POBA) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Percutaneous Transluminal Angioplasty (PTA) Consumption and Growth Rate (2017-2022)
-
9.2 Global Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Drug-Eluting Balloons Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Drug-Eluting Stents Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Peripheral Intervention Drug-Eluting Devices Market Analysis and Outlook till 2022
-
10.1 Global Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.2.2 Canada Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.2.3 Mexico Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.3.2 UK Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.3.3 Spain Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.3.4 Belgium Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.3.5 France Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.3.6 Italy Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.3.7 Denmark Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.3.8 Finland Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.3.9 Norway Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.3.10 Sweden Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.3.11 Poland Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.3.12 Russia Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.3.13 Turkey Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.4.2 Japan Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.4.3 India Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.4.4 South Korea Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.4.5 Pakistan Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.4.6 Bangladesh Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.4.7 Indonesia Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.4.8 Thailand Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.4.9 Singapore Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.4.10 Malaysia Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.4.11 Philippines Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.4.12 Vietnam Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.5.2 Colombia Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.5.3 Chile Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.5.4 Argentina Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.5.5 Venezuela Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.5.6 Peru Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.5.7 Puerto Rico Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.5.8 Ecuador Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.6.2 Kuwait Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.6.3 Oman Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.6.4 Qatar Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.6.5 Saudi Arabia Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.6.6 United Arab Emirates Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.7.2 South Africa Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.7.3 Egypt Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.7.4 Algeria Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
-
10.8.2 New Zealand Peripheral Intervention Drug-Eluting Devices Consumption (2017-2022)
11 Global Peripheral Intervention Drug-Eluting Devices Competitive Analysis
-
11.1 Medtronic plc
-
11.1.1 Medtronic plc Company Details
-
11.1.2 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Main Business and Markets Served
-
11.1.4 Medtronic plc Peripheral Intervention Drug-Eluting Devices Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Biosensors International Group Ltd
-
11.2.1 Biosensors International Group Ltd Company Details
-
11.2.2 Biosensors International Group Ltd Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Biosensors International Group Ltd Peripheral Intervention Drug-Eluting Devices Main Business and Markets Served
-
11.2.4 Biosensors International Group Ltd Peripheral Intervention Drug-Eluting Devices Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Boston Scientific Corporation
-
11.3.1 Boston Scientific Corporation Company Details
-
11.3.2 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Main Business and Markets Served
-
11.3.4 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 B Braun Melsungen AG
-
11.4.1 B Braun Melsungen AG Company Details
-
11.4.2 B Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 B Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Main Business and Markets Served
-
11.4.4 B Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Cardinal Health
-
11.5.1 Cardinal Health Company Details
-
11.5.2 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Main Business and Markets Served
-
11.5.4 Cardinal Health Peripheral Intervention Drug-Eluting Devices Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Terumo Corporation
-
11.6.1 Terumo Corporation Company Details
-
11.6.2 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Main Business and Markets Served
-
11.6.4 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 St Jude Medical Inc
-
11.7.1 St Jude Medical Inc Company Details
-
11.7.2 St Jude Medical Inc Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 St Jude Medical Inc Peripheral Intervention Drug-Eluting Devices Main Business and Markets Served
-
11.7.4 St Jude Medical Inc Peripheral Intervention Drug-Eluting Devices Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 CR Bard Inc
-
11.8.1 CR Bard Inc Company Details
-
11.8.2 CR Bard Inc Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 CR Bard Inc Peripheral Intervention Drug-Eluting Devices Main Business and Markets Served
-
11.8.4 CR Bard Inc Peripheral Intervention Drug-Eluting Devices Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 The Lubrizol Corporation
-
11.9.1 The Lubrizol Corporation Company Details
-
11.9.2 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Main Business and Markets Served
-
11.9.4 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Abbott Laboratories
-
11.10.1 Abbott Laboratories Company Details
-
11.10.2 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Main Business and Markets Served
-
11.10.4 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product Portfolio
-
11.10.5 Recent Research and Development Strategies
12 Global Peripheral Intervention Drug-Eluting Devices Market Outlook by Types and Applications to 2028
-
12.1 Global Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Plain Old Balloon Angioplasty (POBA) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Percutaneous Transluminal Angioplasty (PTA) Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Drug-Eluting Balloons Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Peripheral Intervention Drug-Eluting Devices Market Analysis and Outlook to 2028
-
13.1 Global Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.2.2 Canada Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.2.3 Mexico Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.3.2 UK Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.3.3 Spain Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.3.4 Belgium Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.3.5 France Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.3.6 Italy Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.3.7 Denmark Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.3.8 Finland Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.3.9 Norway Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.3.10 Sweden Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.3.11 Poland Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.3.12 Russia Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.3.13 Turkey Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.4.2 Japan Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.4.3 India Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.4.4 South Korea Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.4.8 Thailand Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.4.9 Singapore Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.4.11 Philippines Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.5.2 Colombia Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.5.3 Chile Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.5.4 Argentina Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.5.6 Peru Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.6.3 Oman Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.6.4 Qatar Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.7.2 South Africa Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.7.3 Egypt Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.7.4 Algeria Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Peripheral Intervention Drug-Eluting Devices
-
Figure of Peripheral Intervention Drug-Eluting Devices Picture
-
Table Global Peripheral Intervention Drug-Eluting Devices Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Peripheral Intervention Drug-Eluting Devices Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Plain Old Balloon Angioplasty (POBA) Consumption and Growth Rate (2017-2022)
-
Figure Global Percutaneous Transluminal Angioplasty (PTA) Consumption and Growth Rate (2017-2022)
-
Figure Global Drug-Eluting Balloons Consumption and Growth Rate (2017-2022)
-
Figure Global Drug-Eluting Stents Consumption and Growth Rate (2017-2022)
-
Figure Global Peripheral Intervention Drug-Eluting Devices Consumption by Country (2017-2022)
-
Table North America Peripheral Intervention Drug-Eluting Devices Consumption by Country (2017-2022)
-
Figure United States Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Canada Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Mexico Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Table Europe Peripheral Intervention Drug-Eluting Devices Consumption by Country (2017-2022)
-
Figure Germany Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure UK Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Spain Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Belgium Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure France Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Italy Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Denmark Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Finland Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Norway Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Sweden Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Poland Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Russia Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Turkey Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Table APAC Peripheral Intervention Drug-Eluting Devices Consumption by Country (2017-2022)
-
Figure China Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Japan Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure India Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure South Korea Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Thailand Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Singapore Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Philippines Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Table South America Peripheral Intervention Drug-Eluting Devices Consumption by Country (2017-2022)
-
Figure Brazil Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Colombia Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Chile Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Argentina Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Peru Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Table GCC Peripheral Intervention Drug-Eluting Devices Consumption by Country (2017-2022)
-
Figure Bahrain Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Oman Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Qatar Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Table Africa Peripheral Intervention Drug-Eluting Devices Consumption by Country (2017-2022)
-
Figure Nigeria Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure South Africa Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Egypt Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure Algeria Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Table Oceania Peripheral Intervention Drug-Eluting Devices Consumption by Country (2017-2022)
-
Figure Australia Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2017-2022)
-
Table Medtronic plc Company Details
-
Table Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medtronic plc Peripheral Intervention Drug-Eluting Devices Main Business and Markets Served
-
Table Medtronic plc Peripheral Intervention Drug-Eluting Devices Product Portfolio
-
Table Biosensors International Group Ltd Company Details
-
Table Biosensors International Group Ltd Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biosensors International Group Ltd Peripheral Intervention Drug-Eluting Devices Main Business and Markets Served
-
Table Biosensors International Group Ltd Peripheral Intervention Drug-Eluting Devices Product Portfolio
-
Table Boston Scientific Corporation Company Details
-
Table Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Main Business and Markets Served
-
Table Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolio
-
Table B Braun Melsungen AG Company Details
-
Table B Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table B Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Main Business and Markets Served
-
Table B Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product Portfolio
-
Table Cardinal Health Company Details
-
Table Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cardinal Health Peripheral Intervention Drug-Eluting Devices Main Business and Markets Served
-
Table Cardinal Health Peripheral Intervention Drug-Eluting Devices Product Portfolio
-
Table Terumo Corporation Company Details
-
Table Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Terumo Corporation Peripheral Intervention Drug-Eluting Devices Main Business and Markets Served
-
Table Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolio
-
Table St Jude Medical Inc Company Details
-
Table St Jude Medical Inc Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table St Jude Medical Inc Peripheral Intervention Drug-Eluting Devices Main Business and Markets Served
-
Table St Jude Medical Inc Peripheral Intervention Drug-Eluting Devices Product Portfolio
-
Table CR Bard Inc Company Details
-
Table CR Bard Inc Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table CR Bard Inc Peripheral Intervention Drug-Eluting Devices Main Business and Markets Served
-
Table CR Bard Inc Peripheral Intervention Drug-Eluting Devices Product Portfolio
-
Table The Lubrizol Corporation Company Details
-
Table The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Main Business and Markets Served
-
Table The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolio
-
Table Abbott Laboratories Company Details
-
Table Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Main Business and Markets Served
-
Table Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product Portfolio
-
Figure Global Plain Old Balloon Angioplasty (POBA) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Percutaneous Transluminal Angioplasty (PTA) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug-Eluting Balloons Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Country (2022-2028)
-
Table North America Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Country (2022-2028)
-
Figure United States Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Country (2022-2028)
-
Figure Germany Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Country (2022-2028)
-
Figure China Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Country (2022-2028)
-
Figure Brazil Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Country (2022-2028)
-
Figure Australia Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Peripheral Intervention Drug-Eluting Devices Consumption Forecast and Growth Rate (2022-2028)
-
